Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sphincter preservation in four consecutive phase II studies of preoperative chemoradiation: analysis of 247 T3 rectal cancer patients.
Gambacorta MA, Valentini V, Coco C, Manno A, Doglietto GB, Ratto C, Cosimelli M, Miccichè F, Maurizi F, Tagliaferri L, Mantini G, Balducci M, La Torre G, Barbaro B, Picciocchi A. Gambacorta MA, et al. Among authors: la torre g. Tumori. 2007 Mar-Apr;93(2):160-9. doi: 10.1177/030089160709300209. Tumori. 2007. PMID: 17557563 Clinical Trial.
Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R, Barbera F, Maranzano E, Lupattelli M. Valentini V, et al. Among authors: la torre g. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):403-12. doi: 10.1016/j.ijrobp.2007.06.025. Epub 2007 Oct 4. Int J Radiat Oncol Biol Phys. 2008. PMID: 17919844 Clinical Trial.
Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G. Capirci C, et al. Among authors: la torre g. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):99-107. doi: 10.1016/j.ijrobp.2007.12.019. Epub 2008 Apr 11. Int J Radiat Oncol Biol Phys. 2008. PMID: 18407433
Survival after radiotherapy in gastric cancer: systematic review and meta-analysis.
Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D'Agostino G, D'Angelo E, Dinapoli N, Nicolotti N, Valentini C, La Torre G. Valentini V, et al. Among authors: la torre g. Radiother Oncol. 2009 Aug;92(2):176-83. doi: 10.1016/j.radonc.2009.06.014. Epub 2009 Jul 6. Radiother Oncol. 2009. PMID: 19586672 Review.
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.
Morganti AG, Massaccesi M, La Torre G, Caravatta L, Piscopo A, Tambaro R, Sofo L, Sallustio G, Ingrosso M, Macchia G, Deodato F, Picardi V, Ippolito E, Cellini N, Valentini V. Morganti AG, et al. Among authors: la torre g. Ann Surg Oncol. 2010 Jan;17(1):194-205. doi: 10.1245/s10434-009-0762-4. Epub 2009 Oct 24. Ann Surg Oncol. 2010. PMID: 19856029 Review.
The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer.
Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, Alfieri S, D'Ugo D, Persiani R, Deodato F, Crucitti A, Lupattelli M, Mantello G, Navarria F, Belluco C, Buonadonna A, Boso C, Lonardi S, Caravatta L, Barba MC, Vecchio FM, Maranzano E, Genovesi D, Doglietto GB, Morganti AG, La Torre G, Pucciarelli S, De Paoli A. Valentini V, et al. Among authors: la torre g. Radiother Oncol. 2019 May;134:110-118. doi: 10.1016/j.radonc.2018.11.023. Epub 2019 Feb 7. Radiother Oncol. 2019. PMID: 31005204 Clinical Trial.
633 results